Previous Article | Next Article ![]()
Journal of Virology, June 2000, p. 5679-5690, Vol. 74, No. 12
Partners AIDS Research Center, Massachusetts General
Hospital, Charlestown, Massachusetts 021291;
Division of Infectious Diseases, The Children's
Hospital,2 and Section of Pediatric
Infectious Diseases, Boston Medical Center,7
Boston, Massachusetts 02118; Department of Paediatrics,
University of Natal,3 and Natal Blood
Transfusion Service, Pinetown,5 Durban,
South Africa; and MRC Human Immunology Unit, Institute of
Molecular Medicine, John Radcliffe Hospital, Oxford OX3
9DU,4 and Oxford Transplant Centre,
Churchill Hospital, Oxford OX3 7LJ,6 United
Kingdom
Received 11 January 2000/Accepted 28 March 2000
Cytotoxic T-lymphocyte (CTL) activity plays a central role in
control of viral replication and in determining outcome in cases of
human immunodeficiency virus type 1 (HIV-1) infection. Incorporation of
important CTL epitope sequences into candidate vaccines is, therefore,
vital. Most CTL studies have focused upon small numbers of adult
Caucasoid subjects infected with clade-B virus, whereas the global
epidemic is most severe in sub-Saharan African populations and
predominantly involves clade-C infection in both adults and children.
In this study, sensitive enzyme-linked immunospot (elispot) assays have
been utilized to identify the dominant Gag-specific CTL epitopes
targeted by adults and children infected with clade-B or -C virus.
Cohorts evaluated included 44 B-clade-infected Caucasoid American and
African American adults and children and 37 C-clade-infected African
adults and children from Durban, South Africa. The results show that 3 out of 46 peptides spanning p17Gag and p24Gag
sequences tested contain two-thirds of the dominant Gag-specific epitopes, irrespective of the clade, ethnicity, or age group studied. However, there were distinctive differences between the dominant responses made by Caucasoids and Africans. Dominant responses in
Caucasoids were more often within p17Gag peptide residues
16 to 30 (38 versus 12%; P < 0.01), while
p24Gag peptide residues 41 to 60 contained the dominant Gag
epitope more often in the African subjects tested (39 versus 4%;
P < 0.005). Within this 20-mer p24Gag, an
epitope presented by both B42 and B81 is defined which represents the
dominant Gag response in >30% of the total infected population in
Durban. This epitope is closely homologous with dominant HIV-2 and
simian immunodeficiency virus Gag-specific CTL epitopes. The fine
focusing of dominant CTL responses to these few regions of high
immunogenicity is of significance to vaccine design.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Differential Narrow Focusing of Immunodominant
Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte
Responses in Infected African and Caucasoid Adults and
Children
*
Corresponding author. Mailing address: Partners AIDS
Research Center, Massachusetts General Hospital, 13th St., Bldg. 149, Rm. 5218, Charlestown, MA 02129. Phone: (617) 726-5787. Fax: (617) 726-5411. E-mail: goulder{at}helix.mgh.harvard.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|